| scholarly article | Q13442814 |
| P50 | author | Mary Cushman | Q40845084 |
| Scott M. Grundy | Q56230139 | ||
| Nader Rifai | Q87727132 | ||
| Daniel Levy | Q88264418 | ||
| Peter Wilson | Q89854449 | ||
| Darwin R. Labarthe | Q96585699 | ||
| Christie M. Ballantyne | Q98665268 | ||
| P2093 | author name string | Christine M Pfeiffer | |
| Gary L Myers | |||
| Gerald R Cooper | |||
| NACB LMPG Committee Members | |||
| Robert H M Christenson | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| biomarker | Q864574 | ||
| P304 | page(s) | 378-384 | |
| P577 | publication date | 2008-12-23 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease | |
| P478 | volume | 55 |
| Q37435149 | 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations |
| Q28397849 | A Cross-Sectional Study of the Cardiovascular Effects of Welding Fumes |
| Q38222549 | A review of the evidence on smoking bans and incidence of heart disease. |
| Q33757446 | A-FABP concentration is more strongly associated with cardiometabolic risk factors and the occurrence of metabolic syndrome in premenopausal than in postmenopausal middle-aged women |
| Q49223170 | ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels |
| Q26785463 | Biomarkers of Nutrition for Development-Folate Review |
| Q37730345 | Body mass index and glycemic control influence lipoproteins in children with type 1 diabetes |
| Q37343374 | C-reactive Protein Concentration Is Associated With a Higher Risk of Mortality in a Rural Korean Population. |
| Q37273542 | C-reactive protein and B-type natriuretic peptide yield either a non-significant or a modest incremental value to traditional risk factors in predicting long-term overall mortality in older adults |
| Q96231569 | C-reactive protein gene rs1205 polymorphism is associated with low-grade chronic inflammation in postmenopausal women |
| Q37021409 | C-reactive protein, fibrinogen, and cardiovascular disease prediction |
| Q37599325 | C-reactive protein: clinical and epidemiological perspectives. |
| Q37729881 | C-reactive protein: risk factor, biomarker and/or therapeutic target? |
| Q28268282 | CRP in cardiovascular disease |
| Q91936284 | Combined associations of hs-CRP and cognitive function with all-cause mortality among oldest-old adults in Chinese longevity areas: a prospective cohort study |
| Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
| Q36079167 | Creating the Future of Evidence-Based Nutrition Recommendations: Case Studies from Lipid Research |
| Q92509120 | Evaluation of Molecularly Imprinted Polymers for Point-of-Care Testing for Cardiovascular Disease |
| Q37470277 | From evidence to practice: consensus in cardiovascular risk assessment and diabetes |
| Q39065651 | Grape Polyphenols' Effects in Human Cardiovascular Diseases and Diabetes. |
| Q36061533 | Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study |
| Q37371016 | High sensitivity C-reactive protein distribution in the elderly: the Bambuí Cohort Study, Brazil |
| Q35017096 | High-sensitive factor I and C-reactive protein based biomarkers for coronary artery disease |
| Q24239981 | Homocysteine lowering interventions for preventing cardiovascular events |
| Q24186605 | Homocysteine-lowering interventions for preventing cardiovascular events |
| Q24201783 | Homocysteine-lowering interventions for preventing cardiovascular events |
| Q42905345 | Inflammation, high-sensitivity C-reactive protein, and vascular protection. |
| Q39867930 | Integrating biomarkers: the new frontier? |
| Q84984913 | Interpretation of Mendelian Randomization Studies and the Search for Causal Pathways in Atherothrombosis: The Need for Caution |
| Q28654304 | Lipid-related markers and cardiovascular disease prediction |
| Q92617611 | Lycopene attenuates LPS-induced liver injury by inactivation of NF-κB/COX-2 signaling |
| Q35130714 | Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials |
| Q93365348 | Moderate increases in daily step count are associated with reduced IL6 and CRP in women with PCOS |
| Q37509262 | Moving toward new statin guidelines in a post-JUPITER world: principles to consider |
| Q44699622 | Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells |
| Q37570183 | Nutritional Status in Adults with Predialysis Chronic Kidney Disease: KNOW-CKD Study |
| Q92692917 | OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions |
| Q24289043 | Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study |
| Q94896489 | Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial |
| Q28397665 | Secondhand Smoke Exposure and Subclinical Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis |
| Q40998882 | Serum Cystatin C and the Risk of Coronary Heart Disease in Ethnic Chinese Patients With Normal Renal Function |
| Q35997173 | Severe multivessel coronary artery disease and high-sensitive troponin T. |
| Q34424962 | Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes |
| Q35994613 | Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality |
| Q35671503 | Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk |
| Q47159698 | The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women |
| Q33597063 | The protective effect of phaseolus vulgaris on cataract in type 2 diabetes: a profitable hypothesis |
| Q36423616 | Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010 |
| Q34811590 | Update on the NCEP ATP-III emerging cardiometabolic risk factors |
| Q43480625 | Use of novel and conventional biomarkers for management of patients with heart failure |
| Q28253143 | Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors |
Search more.